Reference interval determination for anabasine: A biomarker of active tobacco use

Journal of Analytical Toxicology

Volumn 38, Issue 7, 2014, Pages 416-420

  Suh Lailam, Brenda B ^a   Haglock Adler, Carrie J ^b   Carlisle, Heidi J ^b   Ohman, Trent ^b   McMillin, Gwendolyn A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABASINE; BIOLOGICAL MARKER; NICOTINE; NICOTINE GUM;

ACTIVE TOBACCO USE; ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; REFERENCE VALUE; RETROSPECTIVE STUDY; TOBACCO USE; URINALYSIS; URINE LEVEL; CALIBRATION; LIQUID CHROMATOGRAPHY; METABOLISM; PATIENT COMPLIANCE; PROCEDURES; QUESTIONNAIRE; REPRODUCIBILITY; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; URINE;

ANABASINE; BIOLOGICAL MARKERS; CALIBRATION; CHROMATOGRAPHY, LIQUID; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; NICOTINE; PATIENT COMPLIANCE; QUESTIONNAIRES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; TOBACCO USE CESSATION PRODUCTS;

EID: 84907348394     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku059     Document Type: Article

References (23)

1. Benowitz, N.L. (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. The New England Journal of Medicine, 319, 1318-1330.
2. Yildiz, D. (2004) Nicotine, its metabolism and an overview of its biological effects. Toxicon: Official Journal of the International Society on Toxinology, 43, 619-632.
3. Bergen, A.W., Caporaso, N. (1999) Cigarette smoking. Journal of the National Cancer Institute, 91, 1365-1375.
4. Centers for Disease Control and Prevention. (2002) Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR: Morbidity and Mortality Weekly Report, 51, 300-303.
5. Wing, K.J., Fisher, C.G., O'Connell, J.X., Wing, P.C. (2000) Stopping nicotine exposure before surgery. The effect on spinal fusion in a rabbit model. Spine, 25, 30-34.
6. Ehlers, S.L., Rodrigue, J.R., Widows, M.R., Reed, A.I., Nelson, D.R. (2004) Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 10, 412-417.
7. Kaufman, T., Eichenlaub, E.H., Levin, M., Hurwitz, D.J., Klain, M. (1984) Tobacco smoking: Impairment of experimental flap survival. Annals of Plastic Surgery, 13, 468-472.
8. Henningfield, J.E., Fant, R.V., Buchhalter, A.R., Stitzer, M.L. (2005) Pharmacotherapy for nicotine dependence. CA: A Cancer Journal for Clinicians, 55, 281-299; quiz 322-283, 325.
9. Marrs, T.C. Mammalian Toxicology of Insecticides; Royal Society of Chemistry, London, 2012. pp. 280-282.
10. Moyer, T.P., Charlson, J.R., Enger, R.J., Dale, L.C., Ebbert, J.O., Schroeder, D.R. et al. (2002) Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clinical Chemistry, 48, 1460-1471.
11. Jacob, P., III, Yu, L., Shulgin, A.T., Benowitz, N.L. (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. American Journal of Public Health, 89, 731-736.
12. MacBean, C. (ed.) A World Compendium. The Pesticide Manual; 16th edition. British Crop Production Council, BCPC, UK, 2012. 19 pp.
13. Krieger, R. Handbook of Pesticide Toxicology Principles; Academic Press, San Diego, CA, 2001, 121 pp.
14. Krieger, R. Hayes' Handbook of Pesticide Toxicology. Academic Press, San Diego, CA, 2010. pp. 134-135.
15. Westenberger, B.J. (2009) Evaluation of e-cigarettes. Department of Health and Human Services, Food and Drug Administration. http:// www.fda.gov/downloads/drugs/scienceresearch/ucm173250.pdf (accessed 7 November 2013).
16. Wynder, E.L., Hoffmann, D. Tobacco and Tobacco Smoke. Studies in Experimental Carcinogenesis; Academic press, New York, 1967. 730 pp.
17. Hoffmann, D., Djordjevic, M.V., Hoffmann, I. (1997) The changing cigarette. Preventive Medicine, 26, 427-434.
18. Benowitz, N.L. (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews, 18, 188-204.
19. Jarvis, M.J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., Saloojee, Y. (1987) Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health, 77, 1435-1438.
20. Gilbert, D.D. (1993) Chemical analyses as validators in smoking cessation programs. Journal of Behavioral Medicine, 16, 295-308.
21. SRNT Subcommittee on Biochemical Verification. (2002) Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 4, 149-159.
22. Jacob, P., III, Hatsukami, D., Severson, H., Hall, S., Yu, L., Benowitz, N.L. (2002) Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 11, 1668-1673.
23. Jacob, P., III, Yu, L., Liang, G., Shulgin, A.T., Benowitz, N.L. (1993) Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. Journal of Chromatography, 619, 49-61.